Industrial Analysis Report Of the Global Multiple Sclerosis Therapeutics Market With Forecast Assessment Till 2030
Pune, Maharashtra, September 19 2022 (Wiredrelease) Market.Biz --:The global Multiple Sclerosis Therapeutics market size was valued at $ 16,714.4 Mn in 2021 and is anticipated to reach $ 20,256.4 Mn by 2030, with a CAGR of 1.9% during the forecast period. Manufacturers will likely make changes to their product lines to meet the growing demand for high-quality, fast-acting drugs and to address the unmet needs of the progressive form multiple sclerosis market. Plegridy was launched by Biogen Idec, which is a PEGylated long-acting version of its interferon Avonex. Report Description Global Multiple Sclerosis Therapeutics Market Report provides a detailed analysis…
- Date: September 19, 2022
- Author: Quintero
- Category: PharmiWeb